BIOMAT Database Logo BIOMAT Database Logo

Peripheral blood monocyte migration in lung transplant recipients. 1993

R M Hoffman, and J H Dauber, and I L Paradis, and B P Griffith
Department of Medicine, University of Pittsburgh School of Medicine, Pennsylvania.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D009000 Monocytes Large, phagocytic mononuclear leukocytes produced in the vertebrate BONE MARROW and released into the BLOOD; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles. Monocyte
D009240 N-Formylmethionine Leucyl-Phenylalanine A formylated tripeptide originally isolated from bacterial filtrates that is positively chemotactic to polymorphonuclear leucocytes, and causes them to release lysosomal enzymes and become metabolically activated. F-Met-Leu-Phe,N-Formyl-Methionyl-Leucyl-Phenylalanine,Formylmet-Leu-Phe,Formylmethionyl Peptide,Formylmethionyl-Leucyl-Phenylalanine,Formylmethionylleucylphenylalanine,N-Formylated Peptide,N-formylmethionyl-leucyl-phenylalanine,fMet-Leu-Phe,F Met Leu Phe,Formylmet Leu Phe,Formylmethionyl Leucyl Phenylalanine,Leucyl-Phenylalanine, N-Formylmethionine,N Formyl Methionyl Leucyl Phenylalanine,N Formylated Peptide,N Formylmethionine Leucyl Phenylalanine,N formylmethionyl leucyl phenylalanine,Peptide, Formylmethionyl,Peptide, N-Formylated,fMet Leu Phe
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D002465 Cell Movement The movement of cells from one location to another. Distinguish from CYTOKINESIS which is the process of dividing the CYTOPLASM of a cell. Cell Migration,Locomotion, Cell,Migration, Cell,Motility, Cell,Movement, Cell,Cell Locomotion,Cell Motility,Cell Movements,Movements, Cell
D002634 Chemotaxis, Leukocyte The movement of leukocytes in response to a chemical concentration gradient or to products formed in an immunologic reaction. Leukotaxis,Leukocyte Chemotaxis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000704 Analysis of Variance A statistical technique that isolates and assesses the contributions of categorical independent variables to variation in the mean of a continuous dependent variable. ANOVA,Analysis, Variance,Variance Analysis,Analyses, Variance,Variance Analyses
D016040 Lung Transplantation The transference of either one or both of the lungs from one human or animal to another. Grafting, Lung,Transplantation, Lung,Graftings, Lung,Lung Grafting,Lung Graftings,Lung Transplantations,Transplantations, Lung

Related Publications

R M Hoffman, and J H Dauber, and I L Paradis, and B P Griffith
Regulatory CD4+CD25+ T cells in the peripheral blood of lung transplant recipients: correlation with transplant outcome.
March 2004, Transplantation,
R M Hoffman, and J H Dauber, and I L Paradis, and B P Griffith
Peripheral blood eosinophilia as a marker of acute cellular rejection in lung transplant recipients.
April 2022, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation,
R M Hoffman, and J H Dauber, and I L Paradis, and B P Griffith
Aprotinin reduces blood loss in lung transplant recipients.
April 1995, The Annals of thoracic surgery,
R M Hoffman, and J H Dauber, and I L Paradis, and B P Griffith
Up-regulation of interleukin-8, interleukin-10, monocyte chemotactic protein-1, and monocyte chemotactic protein-3 in peripheral blood monocytes in stable lung transplant recipients: are immunosuppression regimens working?
February 2005, Transplantation,
R M Hoffman, and J H Dauber, and I L Paradis, and B P Griffith
Lung rejection occurs in lung transplant recipients with blood chimerism.
July 1997, Transplantation,
R M Hoffman, and J H Dauber, and I L Paradis, and B P Griffith
Peripheral CD19+CD24highCD38high B-regulatory cells in lung transplant recipients.
December 2019, Transplant immunology,
R M Hoffman, and J H Dauber, and I L Paradis, and B P Griffith
Better clinical outcome in renal transplant recipients with peripheral blood microchimerism.
November 2000, Transplantation proceedings,
R M Hoffman, and J H Dauber, and I L Paradis, and B P Griffith
Peripheral blood regulatory T cells in long-term kidney transplant recipients.
January 2009, Transplantation proceedings,
R M Hoffman, and J H Dauber, and I L Paradis, and B P Griffith
Analysis of long term CD4+CD25highCD127- T-reg cells kinetics in peripheral blood of lung transplant recipients.
July 2017, BMC pulmonary medicine,
R M Hoffman, and J H Dauber, and I L Paradis, and B P Griffith
Prophylaxis in Lung Transplant Recipients.
January 2023, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
Copied contents to your clipboard!